These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 4267531)
1. Continuous intravenous infusions of 5-fluoro-2'-deoxyuridine in the treatment of solid tumors. DeConti RC; Kaplan SR; Papac RJ; Calabresi P Cancer; 1973 Apr; 31(4):894-8. PubMed ID: 4267531 [No Abstract] [Full Text] [Related]
2. A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion. Moertel CG; Reitemeier RJ; Hahn RG Cancer Res; 1967 Mar; 27(3):549-52. PubMed ID: 4225560 [No Abstract] [Full Text] [Related]
3. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks. Hill GJ; Grage TB; Wilson W; Ansfield FJ J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956 [No Abstract] [Full Text] [Related]
4. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG). Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208 [No Abstract] [Full Text] [Related]
6. [Continuous intra-arterial infusion of 5-fluor-2-deoxyuridine in primary and metastatic liver cancer]. Baden H Ugeskr Laeger; 1968 Apr; 130(17):721-7. PubMed ID: 4301598 [No Abstract] [Full Text] [Related]
7. The value of fluorinated pyrimidines in advanced malignancy. Fennelly JJ; Fitzgerald MX Br J Cancer; 1968 Dec; 22(4):673-82. PubMed ID: 4236543 [No Abstract] [Full Text] [Related]
8. Treatment of cancer with weekly intravenous 5-fluorouracil. Jacobs EM; Luce JK; Wood DA Cancer; 1968 Dec; 22(6):1233-8. PubMed ID: 5705785 [No Abstract] [Full Text] [Related]
9. Long-term, ambulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas. Caballero GA; Ausman RK; Quebbeman EJ Cancer Treat Rep; 1985 Jan; 69(1):13-5. PubMed ID: 3155649 [TBL] [Abstract][Full Text] [Related]
10. Infusion of floxuridine in the treatment of solid tumors. Papac RJ; Calabresi P JAMA; 1966 Jul; 197(4):237-41. PubMed ID: 4287261 [No Abstract] [Full Text] [Related]
11. Mitomycin-C in the therapy of far-advanced malignant tumors. Manheimer LH; Vital J Cancer; 1966 Feb; 19(2):207-12. PubMed ID: 5905463 [No Abstract] [Full Text] [Related]
12. Recent trends in chemotherapy of solid tumors. Oberfield RA Med Clin North Am; 1975 Mar; 59(2):399-409. PubMed ID: 163943 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine. Van Dyk JJ; Clarkson BD; Duschinsky R; Keller O; La Sala E; Krakoff IH Cancer Res; 1967 Nov; 27(11):2129-36. PubMed ID: 4294532 [No Abstract] [Full Text] [Related]